ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 234 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,320,537 | +0.2% | 1,242,050 | -3.9% | 0.00% | 0.0% |
Q2 2023 | $16,281,833 | +22.5% | 1,292,209 | +26.9% | 0.00% | 0.0% |
Q1 2023 | $13,285,900 | +41662.5% | 1,018,156 | -43.5% | 0.00% | -50.0% |
Q4 2022 | $31,813 | -99.9% | 1,803,496 | -4.1% | 0.00% | 0.0% |
Q3 2022 | $28,635,000 | -16.6% | 1,880,193 | -18.8% | 0.00% | -20.0% |
Q2 2022 | $34,336,000 | -45.0% | 2,315,274 | -16.5% | 0.01% | -37.5% |
Q1 2022 | $62,419,000 | -13.9% | 2,771,775 | -29.5% | 0.01% | 0.0% |
Q4 2021 | $72,530,000 | +36.4% | 3,931,208 | -1.2% | 0.01% | +14.3% |
Q3 2021 | $53,187,000 | -21.0% | 3,978,142 | +9.4% | 0.01% | -12.5% |
Q2 2021 | $67,310,000 | +52.5% | 3,636,410 | +23.7% | 0.01% | +33.3% |
Q1 2021 | $44,136,000 | +53.0% | 2,939,398 | +47.1% | 0.01% | +50.0% |
Q4 2020 | $28,855,000 | +2.2% | 1,998,250 | -43.0% | 0.00% | -20.0% |
Q3 2020 | $28,246,000 | +1.6% | 3,504,541 | -14.7% | 0.01% | 0.0% |
Q2 2020 | $27,813,000 | -12.3% | 4,108,309 | -8.8% | 0.01% | -28.6% |
Q1 2020 | $31,726,000 | -19.8% | 4,506,471 | +11.9% | 0.01% | 0.0% |
Q4 2019 | $39,535,000 | -24.2% | 4,028,031 | -15.2% | 0.01% | -30.0% |
Q3 2019 | $52,132,000 | +2.0% | 4,747,957 | +6.3% | 0.01% | 0.0% |
Q2 2019 | $51,131,000 | +280.6% | 4,465,650 | +217.1% | 0.01% | +233.3% |
Q1 2019 | $13,435,000 | -33.3% | 1,408,320 | -32.6% | 0.00% | -40.0% |
Q4 2018 | $20,146,000 | -60.5% | 2,089,749 | -41.6% | 0.01% | -50.0% |
Q3 2018 | $50,974,000 | +40.8% | 3,577,112 | +18.6% | 0.01% | +42.9% |
Q2 2018 | $36,192,000 | +4.1% | 3,015,883 | +7.1% | 0.01% | 0.0% |
Q1 2018 | $34,775,000 | -26.8% | 2,815,770 | -13.8% | 0.01% | -30.0% |
Q4 2017 | $47,528,000 | +94.5% | 3,266,476 | +90.3% | 0.01% | +100.0% |
Q3 2017 | $24,438,000 | -27.7% | 1,716,227 | -35.3% | 0.01% | -37.5% |
Q2 2017 | $33,824,000 | +21.2% | 2,650,782 | +20.5% | 0.01% | +33.3% |
Q1 2017 | $27,897,000 | +108.0% | 2,200,148 | +67.5% | 0.01% | +100.0% |
Q4 2016 | $13,411,000 | -48.8% | 1,313,488 | -34.0% | 0.00% | -50.0% |
Q3 2016 | $26,203,000 | +3.5% | 1,989,575 | -0.2% | 0.01% | 0.0% |
Q2 2016 | $25,308,000 | +5.9% | 1,992,756 | +10.2% | 0.01% | 0.0% |
Q1 2016 | $23,888,000 | -15.9% | 1,808,313 | -2.1% | 0.01% | -14.3% |
Q4 2015 | $28,397,000 | +26.0% | 1,846,350 | +1.6% | 0.01% | +16.7% |
Q3 2015 | $22,539,000 | -81.0% | 1,817,660 | -79.0% | 0.01% | -78.6% |
Q2 2015 | $118,369,000 | +12.7% | 8,652,658 | -1.4% | 0.03% | +16.7% |
Q1 2015 | $105,004,000 | -16.7% | 8,779,533 | -11.1% | 0.02% | -17.2% |
Q4 2014 | $126,053,000 | +42.1% | 9,871,052 | +49.3% | 0.03% | +38.1% |
Q3 2014 | $88,720,000 | +48.9% | 6,613,493 | +78.2% | 0.02% | +40.0% |
Q2 2014 | $59,569,000 | -1.4% | 3,711,490 | +10.7% | 0.02% | -11.8% |
Q1 2014 | $60,429,000 | +19.5% | 3,351,508 | +2.5% | 0.02% | +21.4% |
Q4 2013 | $50,554,000 | +9.0% | 3,269,975 | +4.8% | 0.01% | 0.0% |
Q3 2013 | $46,389,000 | +3088.2% | 3,119,577 | +2676.3% | 0.01% | – |
Q2 2013 | $1,455,000 | – | 112,366 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |